FDA launches Drug Safety Newsletter

Share this article:
The FDA has launched Drug Safety Newsletter, a quarterly digest of post-marketing drug safety reviews, important emerging drug safety issues and recently approved drugs for healthcare professionals. The newsletter is part of FDA's response to the Institute of Medicine's 2006 report, The Future of Drug Safety—Promoting and Protecting the Public.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions